MOTS-C: The Mitochondria-Derived Peptide

Palmetto Peptides Research Team

February 22, 2026

anti-agingmitochondriamots-cpeptidesresearch

MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene — making it one of a small class of biologically active peptides with a mitochondrial rather than nuclear genetic origin. First described by Lee et al. at USC in 2015, MOTS-c is now classified as a mitokine — a mitochondria-derived signaling molecule that communicates mitochondrial stress states to the rest of the cell and organism, regulating metabolic homeostasis, stress resilience, and aging biology.

Mitochondrial Origin: A Unique Biological Identity

The human mitochondrial genome is a 16,569 base pair circular DNA molecule encoding 13 proteins, 22 tRNAs, and 2 rRNAs. The traditional view was that only these 37 genes were encoded in the mitochondrial genome. The discovery that the 12S rRNA gene contains overlapping short open reading frames (sORFs) that produce functional peptides — including MOTS-c, humanin, and the SHLP family — has expanded our understanding of mitochondrial gene expression and represents a paradigm shift in mitochondrial biology.

MOTS-c's amino acid sequence (MRWQEMGYIFYPRKLR) is highly conserved across vertebrate species, suggesting important evolutionary functions. The peptide is produced in mitochondria but can translocate to the cytoplasm and nucleus — particularly under stress conditions — where it modulates gene expression, metabolic enzyme activity, and stress response pathways.

Mechanism of Action

AMPK Activation

The most well-characterized mechanism of MOTS-c is activation of AMP-activated protein kinase (AMPK) — the master cellular energy sensor that responds to declining ATP/AMP ratios and promotes catabolic (energy-generating) pathways while suppressing anabolic (energy-consuming) processes. Research has demonstrated that MOTS-c activates AMPK in skeletal muscle, liver, and adipose tissue, driving metabolic adaptations including:

Enhanced glucose uptake and glycolysis in muscle cells
Increased fatty acid oxidation
Inhibition of lipogenesis
Improved mitochondrial biogenesis signaling

Nuclear Translocation and Stress Response

Under metabolic and oxidative stress conditions, MOTS-c translocates from mitochondria/cytoplasm to the nucleus, where it binds to the promoters of stress-responsive genes. Research has shown MOTS-c upregulates antioxidant genes (including those in the NRF2 pathway) and modulates expression of genes governing mitochondrial quality control. This nucleus-localized activity distinguishes MOTS-c from many metabolic regulators that act exclusively at cytoplasmic enzyme systems.

Folate-Methionine Cycle Modulation

An important mechanism identified in early MOTS-c research involves modulation of the folate cycle — specifically inhibition of the folate cycle enzyme AICAR transformylase (ATIC). This inhibition leads to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), a natural AMPK activator. This ATIC-AICAR-AMPK pathway may represent the primary mechanism by which MOTS-c exerts its insulin-sensitizing and metabolic effects in peripheral tissues.

Key Research Findings

Metabolic Research

The original Lee et al. (2015) study demonstrated that MOTS-c administration in diet-induced obese mice reduced fat mass, improved glucose tolerance, and enhanced insulin sensitivity — effects dependent on AMPK activation. Subsequent research confirmed these findings across multiple metabolic models, establishing MOTS-c as a promising research tool for studying insulin resistance, obesity, and type 2 diabetes biology.

Exercise Physiology

Research has shown that circulating MOTS-c levels increase in response to acute exercise in humans, suggesting it functions as an exercise-induced signal mediating some of exercise's metabolic benefits. Studies have examined whether exogenous MOTS-c supplementation can reproduce exercise-like metabolic adaptations in sedentary animals — findings with implications for sarcopenia research and understanding exercise's systemic benefits at the molecular level.

Aging Research

MOTS-c plasma levels decline with aging in both rodents and humans, paralleling the age-related decline in mitochondrial function and metabolic resilience. Research in aged mice showed that MOTS-c administration improved physical performance, insulin sensitivity, and metabolic flexibility — findings consistent with a role in counteracting somatopause-like metabolic decline. MOTS-c has been proposed as a biomarker of mitochondrial aging and studied alongside other mitokines as part of the emerging "mitochondrial hormesis" research framework.

Relationship to SS-31 Research

MOTS-c and SS-31 represent complementary mitochondria-focused research tools with distinct mechanisms: SS-31 directly stabilizes cardiolipin and protects electron transport chain function at the inner mitochondrial membrane, while MOTS-c acts as a metabolic signaling molecule activating AMPK and stress-response pathways. Together they enable researchers to probe different facets of mitochondrial biology.

Research Protocols

MOTS-c is supplied as a lyophilized powder for reconstitution in bacteriostatic water or isotonic saline. Research protocols in rodent models have used daily or three-times-weekly subcutaneous administration. Plasma MOTS-c measurement by ELISA enables researchers to correlate endogenous levels with metabolic parameters — a useful baseline measurement for studies examining the relationship between mitochondrial signaling and metabolic phenotype.

Frequently Asked Questions

What does it mean that MOTS-c is encoded in the mitochondrial genome?

The mitochondrial genome is maternally inherited and has been co-evolving with the nuclear genome for ~1.5 billion years. Mitochondria-encoded peptides like MOTS-c represent a communication system from mitochondria to the rest of the cell, signaling metabolic state and energy availability. The mitochondrial origin also means MOTS-c expression can vary based on mitochondrial DNA copy number, heteroplasmy, and mitochondrial transcriptional activity — variables relevant to aging and disease research.

How does MOTS-c relate to humanin, another mitokine?

Humanin is a 21-amino acid peptide encoded in the 16S rRNA region of the mitochondrial genome with primarily neuroprotective and anti-apoptotic properties. MOTS-c (12S rRNA region) focuses on metabolic regulation and stress resilience. Together they define the emerging "mitokine" class — mitochondria-derived peptides with broad regulatory functions beyond the organelle of origin.

Can MOTS-c levels be measured in blood?

Yes — MOTS-c is detectable in human plasma using ELISA assays. Research has measured plasma MOTS-c in the context of aging, exercise, and metabolic disease, establishing baseline reference ranges and demonstrating that it functions as a circulating signal rather than acting only locally within mitochondria.

References

Lee C, et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. PMID: 25738459
Reynolds JC, et al. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. PMID: 33737508
Kim KH, et al. (2018). Mitochondrial MOTS-c regulates osteoclastogenesis and bone mass through GSK3β-mediated protein degradation. Science Translational Medicine. PMID: 29514932

Disclaimer: All compounds offered by Palmetto Peptides are strictly for laboratory research and in vitro studies. They are not intended for human consumption, veterinary use, or any therapeutic application. All information provided is for educational and scientific reference only. Palmetto Peptides makes no health claims. Consult a licensed medical professional before handling any research compound.